Industry Trend Analysis
The
global sacral nerve stimulation (SNS) market is expected to be around $3.3
billion by 2025. The market is primarily driven by factors such as increasing
incidence of neurological disorders around the world, rising geriatric
population along with increase in the investment for development of sacral
nerve stimulation products by the key players in the market. Moreover, increase
in the number of patients suffering from overactive bladder (OAB) condition is
also expected to largely contribute to the market growth over the forecast
period. However, factors such as unfavorable reimbursement policies and
side-effects associated with SNS devices can hinder the market growth during
the forecast period.
Get Free Sample of this Report@: http://www.crystalmarketresearch.com/report-sample/HC06144
Product Outlook and Trend Analysis
The
sacral nerve stimulator device is implanted under the skin specifically in the
upper buttock area. The device consists of an implantable pulse generator. A
lead is positioned near the sacral nerve in the lower back through which, a
mild electric impulse is delivered which can positively influence the pelvic
floor muscles and the rectal sphincters. Before the implantation of the
permanent device, patients usually undergo a test to analyze the impact of
nerve stimulation in terms of potential response from the patients. The observations
from the test are analyzed to determine whether the patient is an appropriate
candidate for implanting the permanent device. Implantable SNS devices segment
held a significant share of the overall market in 2016 owing to their
widespread applications for conditions such as fecal and urine incontinence.
Competitive Analysis
The key players
operating in the global sacral nerve stimulation market focus on product
development and approvals in order to introduce advanced SNS solutions for
effectively treating patients suffering from incontinence and secure a larger
share of the global market. For instance, in February 2017, Nuvectra
Corporation filed regulatory submission with the FDA in the U.S. and with the
CE Mark authorities in the Europe for its Virtis sacral nerve stimulation (SNS)
system. Medtronic plc has a dominant share in this market with its strong
product portfolio and distribution network. Some of the key players operating
in this market are, Axonics Modulation Technologies, Inc, Medtronic plc,
Nuvectra Corporation and Cogentix Medical.
Get complete access of the Report @ https://www.crystalmarketresearch.com/report/sacral-nerve-stimulation-market
Sacral Nerve Stimulation
Market Segmentation:
By Product:
- External
SNS Devices
- Implantable
SNS Devices
By Application:
- Urine
Incontinence
- Fecal
Incontinence
- Other
Applications
By Region:
- North America
o U.S
o Canada
o Mexico
- Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
- Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
- Rest of the World
o Brazil
o South Africa
o Saudi Arabia
o Turkey
o United Arab Emirates
o Others
Inquiry
before Buying@ http://www.crystalmarketresearch.com/send-an-enquiry/HC06144
About Crystal Market Research
Crystal
Market Research is a U.S. based market research and business intelligence
company. Crystal offers one stop solution for market research, business
intelligence, and consulting services to help clients make more informed
decisions. It provides both syndicated as well as customized research studies
for its customers spread across the globe. The company offers market
intelligence reports across a broad range of industries including healthcare,
chemicals & materials, technology, automotive, and energy.
Contact Us:
304
South Jones Blvd, Suite 1896,
Las
Vegas NV 89107,
United
States
Toll Free:
+ 1-888-213-4282
Email:
sales@crystalmarketresearch.com
Website:
www.crystalmarketresearch.com
No comments:
Post a Comment